Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study

por Eser, Kadir, Önder, Arif Hakan, Sezer, Emel, Çil, Timuçin, İnal, Ali, Öztürk, Banu, Erçolak, Vehbi, Duman, Berna Bozkurt, Çelik, Halil, Köşeci, Tolga, Kesen, Oğuzhan
Publicado 2022